Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Kinetics of Sequential Metabolism from d-Leucine tol-Leucine via α-Ketoisocaproic Acid in Rat

Hiroshi Hasegawa, Takehisa Matsukawa, Yoshihiko Shinohara and Takao Hashimoto
Drug Metabolism and Disposition December 2002, 30 (12) 1436-1440; DOI: https://doi.org/10.1124/dmd.30.12.1436
Hiroshi Hasegawa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takehisa Matsukawa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshihiko Shinohara
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takao Hashimoto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

d-Leucine is considered to be converted into thel-enantiomer by two steps: oxidative deamination to form α-ketoisocaproic acid (KIC) and subsequent stereospecific reamination of KIC. We investigated the pharmacokinetics of leucine enantiomers and KIC in rats to evaluate how deamination of d-leucine, reamination of KIC, and decarboxylation of KIC were affected to the overall extent that converted d-leucine into thel-enantiomer. After intravenous administrations ofd-[2H7]leucine,l-[2H7]leucine, or [2H7]KIC, their plasma concentrations together with endogenous l-leucine and KIC were determined by gas chromatography-mass spectrometry. The rapid appearances of [2H7]KIC andl-[2H7]leucine were observed after administration ofd-[2H7]leucine, whereas no detectable amount ofd-[2H7]leucine was found after administrations of [2H7]KIC orl-[2H7]leucine. The fraction of conversion from d-[2H7]leucine into [2H7]KIC (FD→KIC) was estimated by using the area under the curve (AUC) of [2H7]KIC on thed-[2H7]leucine administration [AUCKIC(←D)] and that of [2H7]KIC on the [2H7]KIC administration (AUCKIC) to yield 70.1%. The fraction of conversion from [2H7]KIC tol-[2H7]leucine (FKIC→L) was 40.2%. The fraction of conversion fromd-leucine to the l-enantiomer (FD→L) was considered to be the product of FD→KIC and FKIC→L, indicating that 28.2% of d-[2H7]leucine was metabolized to l-[2H7]leucine via [2H7]KIC. These results suggested that the relatively low conversion of d-leucine into thel-enantiomer might depend on irreversible decarboxylation of KIC. Regardless of [2H7]KIC, FD→L was also calculated directly using AUCL(←D) and AUCL to yield 27.5%. There were no differences between the two FD→L values, suggesting that almost all of the formation ofl-[2H7]leucine fromd-[2H7]leucine occurred via [2H7]KIC as an intermediate.

Footnotes

  • This work was supported in part by grants from the Japan Private School Promotion Foundation and the Science Research Promotion Fund, The Promotion and Mutual Aid Corporation for Private Schools of Japan.

  • Abbreviations used are::
    GC-MS
    gas chromatography-mass spectrometry
    KIC
    α-ketoisocaproic acid
    SIM
    selected ion monitoring
    FA→B
    fraction of conversion from compound A to metabolite B
    CL
    clearance
    AUCB(←A)
    AUC of metabolite B formed from compound A
    • Received July 29, 2002.
    • Accepted September 9, 2002.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

 

DMD articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 30 (12)
Drug Metabolism and Disposition
Vol. 30, Issue 12
1 Dec 2002
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Kinetics of Sequential Metabolism from d-Leucine tol-Leucine via α-Ketoisocaproic Acid in Rat
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Kinetics of Sequential Metabolism from d-Leucine tol-Leucine via α-Ketoisocaproic Acid in Rat

Hiroshi Hasegawa, Takehisa Matsukawa, Yoshihiko Shinohara and Takao Hashimoto
Drug Metabolism and Disposition December 1, 2002, 30 (12) 1436-1440; DOI: https://doi.org/10.1124/dmd.30.12.1436

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Kinetics of Sequential Metabolism from d-Leucine tol-Leucine via α-Ketoisocaproic Acid in Rat

Hiroshi Hasegawa, Takehisa Matsukawa, Yoshihiko Shinohara and Takao Hashimoto
Drug Metabolism and Disposition December 1, 2002, 30 (12) 1436-1440; DOI: https://doi.org/10.1124/dmd.30.12.1436
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Improved CYP Reaction Phenotyping
  • Multiple-Concentration Chemical Inhibition Design
  • New Dog P450 3A98 in Gut
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics